ConneX BioMedical, Inc. — Form D/A
ConneX BioMedical, Inc. of BOULDER, CO, a company, filed a Form D amendment with the SEC on 2023-03-17. The offering totals $5.5M, of which $5.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-03-17
- Form: D/A
- Accession: 0001865132-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.2M
- Remaining: $344K
- Minimum investment: $100K
- Investors: 2
- Date of first sale: 2021-05-07
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-401222
Issuer
- Name: ConneX BioMedical, Inc.
- CIK: 0001865132
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1434 SPRUCE STREET, BOULDER, CO, 80302
- Phone: 8473731405
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Christopher E Banas | Director | Boulder, CO |
| Max B Mitchell | Director | Boulder, CO |
| Christopher E Banas | Executive Officer | Boulder, CO |
| Max B Mitchell | Executive Officer | Boulder, CO |
Other filings by this issuer (1)
More